Israel Englander’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,796,738
| Closed | -$192M | – | 6508 |
|
|
2025
Q3 | $192M | Buy |
1,796,738
+1,419,570
| +376% | +$148M | 0.08% | 196 |
|
|
2025
Q2 | $35.7M | Buy |
377,168
+53,623
| +17% | +$3.97M | 0.02% | 1053 |
|
|
2025
Q1 | $20.5M | Buy |
323,545
+152,097
| +89% | +$9.1M | 0.01% | 1482 |
|
|
2024
Q4 | $7.96M | Buy |
171,448
+11,442
| +7% | +$430K | ﹤0.01% | 2393 |
|
|
2024
Q3 | $4.6M | Sell |
160,006
-367,634
| -70% | -$9.05M | ﹤0.01% | 2910 |
|
|
2024
Q2 | $7.63M | Buy |
527,640
+23,567
| +5% | +$344K | ﹤0.01% | 2330 |
|
|
2024
Q1 | $8.11M | Buy |
504,073
+120,722
| +31% | +$2.09M | ﹤0.01% | 2392 |
|
|
2023
Q4 | $7.62M | Sell |
383,351
-550,870
| -59% | -$8.13M | ﹤0.01% | 2421 |
|
|
2023
Q3 | $15.2M | Buy |
934,221
+400,737
| +75% | +$7.72M | 0.01% | 1659 |
|
|
2023
Q2 | $11.3M | Sell |
533,484
-17,278
| -3% | -$368K | 0.01% | 1896 |
|
|
2023
Q1 | $11.1M | Buy |
550,762
+236,709
| +75% | +$5.11M | 0.01% | 1852 |
|
|
2022
Q4 | $8.21M | Buy |
314,053
+234,713
| +296% | +$3.13M | ﹤0.01% | 2346 |
|
|
2022
Q3 | $811K | Buy |
+79,340
| New | +$669K | ﹤0.01% | 4517 |
|
|
2022
Q2 | – | Sell |
-26,799
| Closed | -$134K | – | 7549 |
|
|
2022
Q1 | $134K | Buy |
26,799
+10,830
| +68% | +$63K | ﹤0.01% | 6019 |
|
|
2021
Q4 | $107K | Buy |
15,969
+1,183
| +8% | +$6.04K | ﹤0.01% | 6227 |
|
|
2021
Q3 | $81K | Buy |
+14,786
| New | +$86K | ﹤0.01% | 6492 |
|
|
2020
Q4 | – | Sell |
-10,942
| Closed | -$68 | – | 5618 |
|
|
2020
Q3 | $68 | Buy |
+10,942
| New | +$75.6K | ﹤0.01% | 4276 |
|
Other funds holding VRNA
Israel Englander's VRNA Position: Q4 2025 in Review
Israel Englander sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,796,738 shares — an estimated $192M sold.
Israel Englander first reported a position in VRNA in Q3 2020 and held it in 17 quarters. The position peaked at $192M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Israel Englander reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Israel Englander sold 1,796,738 Verona Pharma shares in Q4 2025, an estimated $192M.
- Israel Englander first reported a position in Verona Pharma in Q3 2020 and held it in 17 quarters.
- Israel Englander's Verona Pharma position peaked at $192M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.